Systematic Review Registration: CRD42024554513
Both compounds' analyses conclude no weight-based dose adjustment is warranted within their trial populations
Avoid injecting into areas with visible veins, scars, or irritations
Other adverse reactions reported in this study and considered clinically relevant were: swelling, irritation, redness Eye disorders: dysphagia, abdominal discomfort, vomiting, diarrhea, dyspepsia, hematochezia Gastrointestinal disorders: peripheral edema, chest discomfort General disorders and administration site conditions: allergic reaction Immune system disorders: memory impairment, dizziness Nervous system disorders: restlessness Psychiatric disorders: dyspnea, throat tightness, dry throat Respiratory, thoracic and mediastinal disorders: urticaria, pruritus Skin and subcutaneous tissue disorders: hot flush Vascular disorders: Experience In Known Or Suspected Cyanide Poisoning Victims Four open-label, uncontrolled, clinical studies (one of which was prospective and three of which were retrospective) were conducted in known or suspected cyanide-poisoning victims

Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: A secondary analysis from the vitamin D and type 2 diabetes (D2d) study